treatment of Ashmari through Shitivaraka Beeja

Efficacy of Shitivaraka Beeja (Celosia argentea Linn.) in the management of Ashmari w.s.r. to Ureteric Calculi – An open labelled randomized standard controlled clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/039998

Enrollment

Registered

2022-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N201- Calculus of ureter

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Stone size up to 8 mm. Cases of Ureteral tone with renal stone will be included. Cases of ureteral stone with mild hydronephrosis will be included. Patients of Ashmari with controlled Hypertension & Diabetic Mellitus.

Exclusion criteria

Exclusion criteria: Stone size more than 8 mm. Stone present in urinary bladder, and in urethra will be excluded Gross Hydronephrosis. Chronic Renal failure. (Sr. Creatinine >2mg/dl will not be included) Acute abdominal pain. Cases which are advised surgical intervention. Severe Hematuria. Co-morbidities like uncontrolled Hypertension, Diabetes Mellitus, Cardiac disorders, Malignancy, Tuberculosis, HIV, HBsAg, VDRL etc.

Design outcomes

Primary

Measure	Time frame
To expel the ureteric stone.Timepoint: Patient will be assessed for one month after treatment course of fourteen days.	—

Secondary

Measure	Time frame
To decrease the chance of recurrence of calculi.Timepoint: Patient will be assessed for one month after treatment course of fourteen days.	—

Countries

India

Contacts

Public ContactDr T S Dudhamal

Institute of Teaching and Research in Ayurveda

drtsdudhamal@gmail.com8849298620

Outcome results